Author Question: For a one-way ANOVA for independent groups source table, the total degrees of freedom is 26, and ... (Read 74 times)

Wadzanai

  • Hero Member
  • *****
  • Posts: 528
For a one-way ANOVA for independent groups source table, the total degrees of freedom is 26,
  and the between-groups degrees of freedom is 2. The within-groups degrees of freedom should
  therefore equal
 
  A) 1 B) 2 C) 14 D) 28 E) 24

Question 2

What should you if you find a significant interaction between the IVs in your factorial design?
 
  A) re-do the study because significant interactions indicate the presence of extraneous
  variables
  B) don't interpret the interaction, just the main effects
  C) don't interpret the main effects, just the interaction
  D) interpret both the main effects and the interaction



cat123

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

E

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library